跳至主要内容
临床试验/NCT05998291
NCT05998291Enrolling By Invitation不适用

Gluteenittomaan Ruokavaliohoitoon Vastaamaton Ihokeliakia

Tampere University Hospital1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2023年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
23
试验地点
1
主要终点
Clinical prognosis

研究概览

简要总结

The main purpose of the study is to find out

  1. the natural course of refractory dermatitis herpetiformis and the development of possible complications
  2. the strictness of gluten-free diet treatment in refractory dermatitis herpetiformis

详细描述

Refractory dermatitis herpetiformis refers to dermatitis herpetiformis unresponsive to gluten-free diet therapy. So far, there is very little knowledge on the course of the disease and the causes and prognosis of refractory celiac disease.

Study patients with refractory dermatitis herpetiformis will be recruited. As a control material dermatitis herpetiformis patients with good response to gluten-free dietary treatment will be recruited.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Study patients:
  • Dermatitis herpetiformis diagnosis
  • Dermatitis herpetiformis rash not responding to a strict gluten-free diet after at least 3 years
  • Control patients:
  • Dermatitis herpetiformis diagnosis
  • Dermatitis herpetiformis with good response to a gluten-free diet

排除标准

  • Study patients:
  • Not following strict gluten-free diet
  • Control patients:
  • Not following a strict gluten-free diet

结局指标

主要结局

Clinical prognosis

时间窗: Baseline

Occurrence of complications

次要结局

  • Dietary adherence GIP test, CDAT, TG2, TG3 and Ema antibodies, anamnesis(Baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验